Thomas P. Burris - Publications, H-index & Citations

Thomas P. Burris

university of florida

73H指数

276论文数

1.8W被引数

收录论文 129

发表时间

BE2012 a novel, REV-ERB antagonist that promotes regenerative myogenesis in vivo with substantially improved pharmacokinetics relative to SR8278 BE2012，一种新颖的REV-ERB拮抗剂，可促进体内再生肌生成，且相对于SR8278具有显著改善的药代动力学

Journal of Pharmacology and Experimental Therapeutics

IF3.8

2026-08-17

PREAI

Isabelle Cote; Aurore C. Valfort; Ryan K. Sanders; Sheryl L. Burris; Matthew E. Hayes; Rhea Arya; Lingaiah Maram; Bahaa Elgendy; Feng Yue; Thomas P. Burris

Pharmacology of Estrogen-Related Receptors (ERRs) Agonists 雌激素相关受体(ERRs)激动剂的药理学

rsc chem. biol.

IF0

2026-05-30

OAAI

Mohammad Radwan; Soumitra Guin; Thomas P. Burris

Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling SLU-PP-332这一运动模拟物的化学优化使其能够深入了解雌激素相关受体信号传导

International Journal of Biological Macromolecules

IF8.5

2026-03-16

OAAI

Hazem Essam Okda; Puhan Zhao; Matt Hayes; Colten Duvall; Elsa Quillin; Hong Fang; Bassem M. Mohammed; Lamees Hegazy; Thomas P. Burris; Bahaa Elgendy

Discovery of BE2012, a First-in-Class REV-ERBα/β Antagonist with Favorable Selectivity and Pharmacokinetics, and In Vivo Efficacy in Inducing Key Myogenic Factors for Muscle Repair upon Acute Muscle Injury

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2025-12-01

PREAI

Maram, Lingaiah; Valfort, Aurore-Cecile; Rahman, Mohammad Homaidur; Okda, Hazem E.; Elagawany, Mohamed; Politte, Henry; Appourchaux, Kevin; Bedia-Diaz, Gonzalo; Cote, Isabelle; Hegazy, Lamees; Burris, Thomas P.; Elgendy, Bahaa

An Orally Active ERR Agonist, SLU-PP-915, Enhances Aerobic Exercise Capacity 一种口服活性的ERR激动剂SLU-PP-915，增强了有氧运动能力

The Journal of Pharmacology and Experimental Therapeutics

IF0

2025-12-01

PREAI

Cyrielle Billon; Kevin Appourchaux; Isabelle Côté; Thomas P. Burris

Limited effects of the REV-ERB agonist SR9009 after mouse spinal cord contusion: Reduced acute pathology with unaffected functional recovery and chronic white matter loss REV-ERB激动剂SR9009在 MOUSE脊髓挫伤后效果有限：急性病理减轻，但功能恢复未受影响且慢性白质丢失。

Neuroscience Letters

IF2

2025-11-12

PREAI

Lukasz P. Slomnicki; Emily Hodges; Christine Armstrong; Johnny Morehouse; Darlene Burke; Sujata Saraswat Ohri; Thomas P. Burris; Michal Hetman

Cold exposure induces the constitutively active thermogenic receptor, GPR3, via ERRα and ERRγ 冷暴露通过ERRα和ERRγ诱导组成性激活的产热受体GPR3。

Molecular Metabolism

IF6.6

2025-10-30

OAAI

Olivia Sveidahl Johansen; Rebecca L. McIntyre; Janane F. Rahbani; Qiaoqiao Zhang; Charlotte Scholtes; Damien Marc Lagarde; Cyrielle Billon; Isabelle Côté; Maria Delgado-Martin; David Tandio; Astrid Linde Basse; Elodie Eury; Anastasia Kralli; Thomas P. Burris; Vincent Giguère; Lawrence Kazak; Zachary Gerhart-Hines

REV-ERBα regulates brain NAD+ levels and tauopathy via an NFIL3–CD38 axis REV-ERBα通过NFIL3–CD38轴调节大脑NAD+水平并影响tauopathy。

Nature Aging

IF19.4

2025-09-01

OAAI

Jiyeon Lee; Ryeonghwa Kang; Sohui Park; Ibrahim O. Saliu; Minsoo Son; Jaymie R. Voorhees; Julie M. Dimitry; Elsa I. Quillin; Lauren N. Woodie; Brian V. Lananna; Li Gan; Young-Ah Goo; Guoyan Zhao; Mitchell A. Lazar; Thomas P. Burris; Erik S. Musiek

Iodine-promoted oxidative cross-coupling for the synthesis of (E)-2-(3-oxo-3-phenylprop-1-en-1-yl)-3-phenylquinazolin-4(3H)-one via C–H activation: development of synthetic TLX agonists 碘促进的氧化交叉偶联反应用于通过C–H活化合成(E)-2-(3-oxo-3-phenylprop-1-en-1-yl)-3-phenylquinazolin-4(3H)-one：合成TLX激动剂的开发

Org. Biomol. Chem.

IF2.7

2025-08-17

OAAI

Lingaiah Maram; Puhan Zhao; Thomas Koelblen; Lamees Hegazy; Thomas P. Burris; Bahaa Elgendy

Development of radioligand binding assays for REV-ERBα and REV-ERB(3 开发针对REV-ERBα和REV-ERBβ的放射性配体结合测定方法

CHEMICAL ENGINEERING JOURNAL

IF13.2

2025-07-01

PREAI

Koelblen, Thomas; Burris, Elise P.; Burris, Thomas P.

Animal models for development of anti-obesity drugs in the age of GLP-1 agents GLP-1药物时代抗肥胖药物开发中的动物模型

EXPERT OPINION ON DRUG DISCOVERY

IF4.9

2025-05-21

PREAI

Alexander Culver; Keith Stayrook; Michele Comerota; Adrian Oblak; Thomas Burris

Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins 肿瘤细胞通过脂肪酸结合蛋白避免免疫细胞诱导的铁死亡。

MOLECULAR CANCER

IF33.9

2025-02-03

OAAI

Freitas-Cortez, Maria Angelica; Masrorpour, Fatemeh; Jiang, Hong; Mahmud, Iqbal; Lu, Yue; Huang, Ailing; Duong, Lisa K.; Wang, Qi; Voss, Tiffany A.; Leyton, Claudia S. Kettlun; Wei, Bo; Chan, Wai-Kin; Lin, Kevin; Zhang, Jie; Tsouko, Efrosini; Ganjoo, Shonik; Barsoumian, Hampartsoum B.; Riad, Thomas S.; Hu, Yun; Leuschner, Carola; Puebla-Osorio, Nahum; Wang, Jing; Hu, Jian; Davies, Michael A.; Puduvalli, Vinay K.; Billon, Cyrielle; Burris, Thomas P.; Lorenzi, Philip L.; Gan, Boyi; Welsh, James W.

The Estrogen Receptor-Related Orphan Receptors Regulate Autophagy through TFEBS S

MOLECULAR PHARMACOLOGY

IF3

2024-10-01

PREAI

Losby, McKenna; Hayes, Matthew; Valfort, Aurore; Sopariwala, Danesh H.; Sanders, Ryan; Walker, John K.; Xu, Weiyi; Narkar, Vihang A.; Zhang, Lilei; Billon, Cyrielle; Burris, Thomas P.

Merging Natural Product Structures with Pharmaceutical Leads: Unnatural Enantiomers of Estranes as Glucocorticoid Receptor Modulators That Suppress TNF-α and IL-6 Release

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-09-06

PREAI

Nicholson, Joshua M.; Yang, Dexi; Koelblen, Thomas; Hu, Eric L.; Coss, Christopher C.; Burris, Thomas P.; Hu, Xiao; Micalizio, Glenn C.

How to Make Glucocorticoids Safer

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2024-03-01

OAAI

Burris, Thomas P.

From Functional Fatty Acids to Potent and Selective Natural-Product-Inspired Mimetics via Conformational Profiling

ACS CENTRAL SCIENCE

IF10.4

2024-02-12

OAAI

Markham, Lauren E.; Koelblen, Thomas; Chobanian, Harry R.; Follis, Ariele Viacava; Burris, Thomas P.; Micalizio, Glenn C.

A Synthetic ERR Agonist Alleviates Metabolic SyndromeS

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2024-02-01

OAAI

Billon, Cyrielle; Schoepke, Emmalie; Avdagic, Amer; Chatterjee, Arindam; Butler, Andrew A.; Elgendy, Bahaa; Walker, John K.; Burris, Thomas P.

Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function

CIRCULATION

IF38.6

2024-01-16

PREAI

Xu, Weiyi; Billon, Cyrielle; Li, Hui; Wilderman, Andrea; Qi, Lei; Graves, Andrea; Rideb, Jernie Rae Dela Cruz; Zhao, Yuanbiao; Hayes, Matthew; Yu, Keyang; Losby, McKenna; Hampton, Carissa S.; Adeyemi, Christiana M.; Hong, Seok Jae; Nasiotis, Eleni; Fu, Chen; Oh, Tae Gyu; Fan, Weiwei; Downes, Michael; Welch, Ryan D.; Evans, Ronald M.; Milosavljevic, Aleksandar; Walker, John K.; Jensen, Brian C.; Pei, Liming; Burris, Thomas; Zhang, Lilei

International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily- Update 2023

PHARMACOLOGICAL REVIEWS

IF17.3

2023-11-01

OAAI

Burris, Thomas P.; de Vera, Ian Mitchelle S.; Cote, Isabelle; Flaveny, Colin A.; Wanninayake, Udayanga S.; Chatterjee, Arindam; Walker, John K.; Steinauer, Nickolas; Zhang, Jinsong; Coons, Laurel A.; Korach, Kenneth S.; Cain, Derek W.; Hollenberg, Anthony N.; Webb, Paul; Forrest, Douglas; Jetten, Anton M.; Edwards, Dean P.; Grimm, Sandra L.; Hartig, Sean; Lange, Carol A.; Richer, Jennifer K.; Sartorius, Carol A.; Tetel, Marc; Billon, Cyrielle; Elgendy, Bahaa; Hegazy, Lamees; Griffett, Kristine; Peinetti, Nahuel; Burnstein, Kerry L.; Hughes, Travis S.; Sitaula, Sadichha; Stayrook, Keitch R.; Culver, Alexander; Murray, Meghan H.; Finck, Brian N.; Cidlowski, John A.

Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-10-01

OAAI

Hampton, Carissa S.; Sitaula, Sadichha; Billon, Cyrielle; Haynes, Keith; Avdagic, Amer; Wanninayake, Udayanga; Adeyemi, Christiana M.; Chatterjee, Arindam; Griffett, Kristine; Banerjee, Subhashis; Burris, Sheryl L.; Schoepke, Emmalie; Boehm, Terri; Bess, Alex; de Vera, Ian Mitchelle S.; Burris, Thomas P.; Walker, John K.

研究方向